CA-104,
1-Acetamidoadamantane,
880-52-4,
N-(1-Adamantyl)acetamide,
N-(adamantan-1-yl)acetamide,
1-Acetylaminoadamantane,
1-Adamantylacetamide,
Acetamide, N-1-adamantyl-,
N-1-Adamantylacetamide,
UNII-5283Y1VOII,
1-Acetamino adamantane,
EINECS 212-914-9,
MFCD00074730,
Acetamide, N-tricyclo[3.3.1.13,7]dec-1-yl-,
NSC 527917,
BRN 2098306,
5283Y1VOII,
Acetamide, N-(1-adamantyl)-,
1-Acetamidotricyclo[3.3.1.1(3,7)]decane,
BCVXYGJCDZPKGV-UHFFFAOYSA-N,
Acetamide, N-tricyclo(3.3.1.13,7)dec-1-yl-,
N-Tricyclo(3.3.1.13,7)dec-1-ylacetamide,
n-adamantylacetamide,
1-Acetamidoadamantane, 99+%,
N-(1-adamantyl)-acetamide,
NSC527917,
N-adamantanylacetamide,
N-Acetyl Adamantamine,
PubChem6387,
1-Acetyladamantanamine,
1-Acetylaminoadamantane;,
Acetamide,7]dec-1-yl-,
N-Acetyl-1-adamantanamine,
ACMC-209qr0,
N-(1-Adamanthyl)acetamide,
N-(1-adamantyl)ethanamide,
AC1L20JX,
4-12-00-00220 (Beilstein Handbook Reference),
N-1-Acetyl-1-adamantanamine,
SCHEMBL133014,
DTXSID9061255,
SCHEMBL14283216,
SCHEMBL19757636,
CTK3E8058,
KS-000017GN,
ZINC3860730,
ANW-38938,
CA-104,
STK355738,
AKOS000472072,
AKOS001064174,
AKOS022142538,
AB02845,
EBD2205180,
LS-8000,
MCULE-2172386682,
NSC-527917,
VZ21087,
NCGC00322546-01,
AC-16090,
AJ-46045,
AN-47910,
K574,
DB-003017,
TR-027646,
A0737,
FT-0629068,
ST24031343,
ST50825353,
Acetamide, N-tricyclo[3.3.1.1]dec-1-yl-,
A-8381,
AB00694312-03,
880A524,
A842454,
N-(tricyclo[3.3.1.1~3,7~]dec-1-yl)acetamide,
acetamide, N-tricyclo[3.3.1.1~3,7~]dec-1-yl-,
I14-0457,
W-100421,
W-200099,
Acetamide, N-tricyclo[3.3.1.1(3,7)-]dec-1-yl-,
Z27687036,
Amantadine Related Compound B, United States Pharmacopeia (USP) Reference Standard,
InChI=1/C12H19NO/c1-8(14)13-12-5-9-2-10(6-12)4-11(3-9)7-12/h9-11H,2-7H2,1H3,(H,13,14,
N- acetamide,
N-(1-Adamantyl)-urea,
C12H19NO,
1-Acetamidoadamantane, 98% 10g,
C12-H19-N-O,
CID64153,
ACN-037069,
CB11125,
CS-O-30529,
N-tricyclo[3.3.1.13,7]dec-1-ylacetamide,
Acetamide, N-tricyclo(3.3.1.1(3,7)-)dec-1-yl-,